Marmorino, F., Salvatore, L., Barbara, C., Allegrini, G., Antonuzzo, L., Masi, G., . . . Cremolini, C. (2017). Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer. Br J Cancer.
Chicago Stili AlıntıMarmorino, Federica, et al. "Serum LDH Predicts Benefit From Bevacizumab Beyond Progression in Metastatic Colorectal Cancer." Br J Cancer 2017.
MLA AlıntıMarmorino, Federica, et al. "Serum LDH Predicts Benefit From Bevacizumab Beyond Progression in Metastatic Colorectal Cancer." Br J Cancer 2017.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..